ERBB2 and ductal breast carcinoma in situ: The distribution of subtypes in this cohort of DCIS samples differs from what is usually seen in IBC, with human epidermal growth factor receptor 2 (HER2) tumors relatively over-represented and Luminal A tumors markedly underrepresented in DCIS (Fig. 1A and B).